title: TLR9-dependent IL-23/IL-17 is required for the generation of Stachybotrys chartarum-induced hypersensitivity pneumonitis.
abstract: Hypersensitivity pneumonitis (HP) is an inflammatory lung disease that develops after repeated exposure to inhaled particulate Ag. Stachybotrys chartarum is a dimorphic fungus that has been implicated in a number of respiratory illnesses, including HP. In this study, we have developed a murine model of S. chartarum-induced HP that reproduces pathology observed in human HP, and we have hypothesized that TLR9-mediated IL-23 and IL-17 responses are required for the generation of granulomatous inflammation induced by inhaled S. chartarum. Mice that undergo i.p. sensitization and intratracheal challenge with 10(6) S. chartarum spores developed granulomatous inflammation with multinucleate giant cells, accompanied by increased accumulation of T cells. S. chartarum sensitization and challenge resulted in robust pulmonary expression of IL-17 and IL-23. S. chartarum-mediated granulomatous inflammation required intact IL-23 or IL-17 responses and required TLR9, because TLR9(-/-) mice displayed reduced IL-17 and IL-23 expression in whole lung associated with decreased accumulation of IL-17 expressing CD4(+) and γδ T cells. Compared with S. chartarum-sensitized dendritic cells (DC) isolated from WT mice, DCs isolated from TLR9(-/-) mice had a reduced ability to produce IL-23 in responses to S. chartarum. Moreover, shRNA knockdown of IL-23 in DCs abolished IL-17 production from splenocytes in response to Ag challenge. Finally, the intratracheal reconstitution of IL-23 in TLR9(-/-) mice recapitulated the immunopathology observed in WT mice. In conclusion, our studies suggest that TLR9 is critical for the development of Th17-mediated granulomatous inflammation in the lung in response to S. chartarum.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA. ubhan@umich.edu
authors.forename: Urvashi
authors.initials: U
authors.lastname: Bhan
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Newstead
authors.forename: Xianying
authors.initials: X
authors.lastname: Zeng
authors.forename: Amy
authors.initials: A
authors.lastname: Podsaid
authors.forename: Moloy
authors.initials: M
authors.lastname: Goswami
authors.forename: Megan N
authors.initials: MN
authors.lastname: Ballinger
authors.forename: Steven L
authors.initials: SL
authors.lastname: Kunkel
authors.forename: Theodore J
authors.initials: TJ
authors.lastname: Standiford
mesh_terms: D000542:Alveolitis, Extrinsic Allergic / Q000235:genetics / Q000276:immunology* / Q000473:pathology*; D000818:Animals; D000946:Antigens, Fungal / Q000008:administration & dosage / Q000276:immunology; D004195:Disease Models, Animal; D006801:Humans; D020381:Interleukin-17 / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D053759:Interleukin-23 / Q000008:administration & dosage / Q000235:genetics / Q000502:physiology*; D007442:Intubation, Intratracheal; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D011994:Recombinant Proteins / Q000008:administration & dosage; D013191:Stachybotrys / Q000276:immunology* / Q000472:pathogenicity; D051217:Toll-Like Receptor 9 / Q000172:deficiency / Q000502:physiology*
chemical_list: D000946:Antigens, Fungal; D020381:Interleukin-17; D053759:Interleukin-23; D011994:Recombinant Proteins; C495370:Tlr9 protein, mouse; D051217:Toll-Like Receptor 9